Research Use Only - Not for human consumption. 18+ only.
Clinical TrialsCosmetic & TopicalTopical

Nonapeptide-1

Also known as: Melanostatine

A potent melanin inhibitor that reduces tyrosinase activity for skin lightening. Used in brightening products for long-term pigmentation treatment.

Research Status

Clinical Trials

Moderate Clinical Data

For research purposes only. Not approved for human use. Not medical advice.

Research Areas

Reduces melanin synthesis and tyrosinase activity
Lightens hyperpigmentation and age spots
Brightens overall skin tone
Supports even skin complexion
Minimizes post-inflammatory hyperpigmentation
Enhances efficacy of other brightening agents

Side Effects

Mild skin irritation or redness
UncommonMild

May occur in sensitive individuals, particularly at higher concentrations (2–3%). Usually resolves within 1–2 weeks of use. Reduce frequency to 1x daily or lower concentration if irritation persists.

Dryness or tightness
UncommonMild

Topical peptides can occasionally cause mild dryness. Use a hydrating moisturizer after application. Ensure adequate hydration.

Contact dermatitis or allergic reaction
RareModerate

Rare but possible in individuals with peptide sensitivity or other ingredient allergies. Perform a patch test on a small area (inner arm or behind ear) for 24–48 hours before full facial application. Discontinue if rash, swelling, or severe itching develops.

Photosensitivity
RareMild

Some tyrosinase inhibitors may increase sun sensitivity. Use broad-spectrum SPF 30+ sunscreen daily during and after treatment.

Uneven lightening or patchy results
UncommonMild

Inconsistent application or variable skin thickness can lead to uneven results. Apply evenly and consistently to affected areas. Results improve with continued use.

Dosing Reference

ParameterValue
Dose range1-3 %
Frequency1-2x daily
TimingMorning and/or evening skincare routine
RouteTopical

Topical application only. Typical concentration in cosmetic formulations ranges from 1–3%. Start with lower concentrations (1%) and increase gradually if well-tolerated. For research purposes only.

Research disclaimer

Figures drawn from published research literature and community logs. Not clinical recommendations. Consult a qualified professional. Research use only.

Reconstitution Guide

Do not use saline or bacteriostatic saline — use only bacteriostatic water for reconstitution

Do not shake the vial vigorously; gentle swirling prevents peptide degradation

Discard immediately if the solution appears cloudy, discolored, or contains visible particles

Use within 30 days of reconstitution when stored at 2–8°C

Do not freeze the reconstituted solution; freezing may denature the peptide

Use the PeptideVolt reconstitution calculator for your exact concentration

Use the PeptideVolt reconstitution calculator for your exact concentration

Molecular and Pharmacological Data

Nonapeptide-1 inhibits tyrosinase, the key enzyme responsible for melanin synthesis. By reducing tyrosinase activity, it decreases the conversion of L-tyrosine to dopaquinone, the first committed step in melanin production. This results in reduced melanin deposition in the epidermis and a gradual lightening of hyperpigmented areas.

Tyrosinase Inhibition

Nonapeptide-1 directly inhibits tyrosinase enzyme activity, preventing the oxidation of tyrosine to melanin precursors. This is the primary mechanism by which the peptide reduces melanin synthesis.

Melanogenesis Suppression

By blocking tyrosinase, the peptide suppresses the overall melanogenesis pathway, reducing melanin production in melanocytes and limiting melanin transfer to keratinocytes.

Pigmentation Reduction

Chronic application leads to gradual reduction in visible hyperpigmentation, age spots, and uneven skin tone as melanin accumulation decreases over time.

  • Nonapeptide-1 is a competitive inhibitor of tyrosinase, the rate-limiting enzyme in melanin biosynthesis
  • The peptide works topically and does not require systemic absorption for efficacy
  • Effects are gradual and cumulative; visible results typically appear after 4–12 weeks of consistent use
  • The peptide is stable in topical formulations and compatible with common skincare ingredients

Track your Nonapeptide-1 research

Free account. No credit card required.

Start Free

Browse the Research Library

40+ peptide profiles with mechanism summaries, dosing data, and reconstitution guides.

View all peptides

Research Use Only. All content on this page is provided for informational and educational purposes related to scientific research. Nonapeptide-1 is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.